IGC Pharma
IGC
#10699
Rank
HK$0.20 B
Marketcap
HK$1.96
Share price
1.59%
Change (1 day)
-39.92%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Market capitalization of IGC Pharma (IGC)

Market cap: HK$0.20 Billion

As of October 2026 IGC Pharma has a market cap of HK$0.20 Billion. This makes IGC Pharma the world's 10699th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of IGC Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.20 B-6.47%
2025HK$0.21 B-2.59%
2024HK$0.22 B59.56%
2023HK$0.13 B5.71%
2022HK$0.13 B-66.07%
2021HK$0.38 B-24.87%
2020HK$0.51 B166.49%
2019HK$0.19 B123.68%
2018HK$86.8 M-60.45%
2017HK$0.21 B256.15%
2016HK$61.61 M93.49%
2015HK$31.84 M-54.88%
2014HK$70.58 M9.66%
2013HK$64.36 M2.41%
2012HK$62.84 M33.58%
2011HK$47.04 M-38.65%
2010HK$76.68 M-44.43%
2009HK$0.13 B82.46%
2008HK$75.64 M-88.23%
2007HK$0.64 B1.28%
2006HK$0.63 B

End of Day market cap according to different sources

On Oct 25th, 2026 the market cap of IGC Pharma was reported to be:

HK$0.19 Billion
by Nasdaq info icon info icon
HK$0.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sterling Infrastructure
STRL
HK$86.56 B 42,607.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
HK$16.10 B 7,843.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
HK$37.77 B 18,536.97%๐Ÿ‡บ๐Ÿ‡ธ USA